Abstract
Abnormal melatonin secretion has been demonstrated in patients with affective disorders such as major depressive disorder (MDD) and bipolar disorder (BD). However, magnetic resonance imaging (MRI) studies that previously investigated the volume of the pineal gland, which regulates circadian rhythms by secreting melatonin, in these patients reported inconsistent findings. The present study employed MRI to examine pineal gland volumes and pineal cyst prevalence in 56 MDD patients (29 currently depressed and 27 remitted patients), 26 BD patients, and matched controls (33 for MDD and 24 for BD). Pineal volumes and cyst prevalence in the current MDD, remitted MDD, and BD groups did not significantly differ from those of the healthy controls. However, pineal gland volumes were significantly smaller in the current MDD subgroup of non-melancholic depression than in the melancholic MDD subgroup. Interestingly, pineal volumes correlated negatively with the severity of loss of interest in the current MDD group. Medication and the number of affective episodes were not associated with pineal volumes in the MDD or BD group. While these results do not suggest that pineal volumes reflect abnormal melatonin secretion in affective disorders, they do point to the possibility that pineal abnormalities are associated with clinical subtypes of MDD and its symptomatology.
Introduction
Circadian rhythm disruption is a hallmark of affective disorders; patients often struggle with sleep-wake cycles, which are regulated by melatonin secreted by the pineal gland. While hormonal studies have long suggested abnormal melatonin levels in Major Depressive Disorder (MDD) and Bipolar Disorder (BD), neuroimaging studies looking for structural correlates—specifically, whether the "melatonin factory" is smaller—have yielded inconsistent results. This study, published in Frontiers in Psychiatry, investigates whether the volume of the pineal gland serves as a structural biomarker for these disorders.
Methods
The researchers employed structural Magnetic Resonance Imaging (MRI) on two distinct cohorts totaling 139 participants:
- MDD Cohort: 56 patients (29 currently depressed, 27 remitted) and 33 matched healthy controls.
- BD Cohort: 26 patients with Bipolar I disorder (currently in a stable/euthymic state) and 24 matched healthy controls.
Imaging was performed using 1.5T scanners to obtain T1-weighted images. A single rater, blinded to diagnoses, manually traced the pineal gland on consecutive coronal slices to calculate both total pineal volume (including cysts) and parenchymal volume (functional tissue only). Clinical correlations were assessed using the Beck Depression Inventory (BDI) and the Mood and Anxiety Symptom Questionnaire (MASQ).
Key Results and Insights
The study found no statistically significant global differences in total or parenchymal pineal volumes between the MDD group, the BD group, and their respective control groups ($p > 0.05$). However, more granular analysis revealed significant associations within clinical subtypes and symptoms.
Subtype Specificity
A striking finding was that pineal volumes were significantly smaller in the non-melancholic MDD subgroup compared to the melancholic subgroup. In currently depressed patients, the non-melancholic subgroup had a mean parenchymal volume of $101.9 \text{ mm}^3$, significantly smaller than the melancholic subgroup's $142.0 \text{ mm}^3$ ($p = 0.014$).
The Anhedonia Connection
Within the currently depressed group, smaller parenchymal volumes correlated strongly with the "loss of interest" (anhedonia) subscore of the MASQ ($r = -0.571, p = 0.002$). This suggests that pineal abnormalities might be tied to the neurobiology of reward and motivation, moving beyond the traditional view of the gland as purely a sleep regulator.
Stability Across States
Pineal volumes did not differ between currently depressed and remitted patients, nor were they affected by medication or the number of past episodes. This suggests that pineal volume might be a stable trait marker—a pre-existing feature—rather than a "state marker" that changes during an active illness phase.
Discussion and Limitations
While these results do not suggest that pineal volumes reflect global abnormal melatonin secretion in affective disorders, they point to the possibility that pineal abnormalities are associated with specific clinical subtypes of MDD and its symptomatology.
Several limitations should be noted:
- Sample Size: Subgroups, particularly the melancholic MDD group ($N=10$), were small, limiting statistical power.
- Scanner Resolution: The 1.5T MRI resolution is lower than modern 3T or 7T standards, which may affect the precision of measuring such a tiny structure (approx. 100–150 $\text{mm}^3$).
- Functional Data: The study lacked direct measurements of melatonin levels, leaving the functional impact of volume differences speculative.
Future research using higher-resolution imaging and longitudinal designs is needed to determine if pineal volume can predict treatment response or relapse risk.
Summary updated